QIAGEN Acquisitions

QIAGEN has acquired 27 companies and its latest acquisition was Verogen, Inc. on Jan 2023

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Verogen, Inc.

Jan 2023

Source »
$150M
Verogen is a California-based company that develops and distributes next-generation gene sequencing panels and genetic code analyzing products for the healthcare sector.
BLIRT S.A.

May 2022

Source »
undisclosed
BLIRT is a Poland-based company that develops, manufactures and commercializes recombinant enzymes for the life science industry.
NeuMoDx Molecular, Inc.

Sep 2020

Source »
$248M
NeuMoDx is a diagnostics company that offers vitro molecular diagnostic testing solutions for hospitals and clinical laboratories.

-

Digital PCR Technology, FORMULATRIX

Jan 2019

Source »
undisclosed
-
N-of-One, Inc.

Jan 2019

Source »
undisclosed
N-of-One is an oncology diagnostics platform that enables clinical interpretation of molecular tests.

Frequently Asked Questions about QIAGEN

  1. What companies did QIAGEN acquire?

    Companies acquired by QIAGEN include Verogen, BLIRT and NeuMoDx
  2. How many acquisitions does QIAGEN have?

    QIAGEN has acquired 27 companies including Verogen, BLIRT and NeuMoDx.
  1. How many acquisitions did QIAGEN make in 2023?

    In 2023 QIAGEN acquired 1 companies including Verogen.